Healthcare
Medibio Limited (ASX:MEB)
Industry Group : Health Care Equipment & Services | Industry Group Name : Health Care Technology
Market Price : AUD 0.0080 (0%)
(as on 2021-10-24 00:55:54)
| Previous Close | Open | Close* | Day Range | 52 WEEK HIGH LOW |
|---|---|---|---|---|
| 0.008 | 0.009 | 0.008 | 0.008L 0.009 H | 0.007L 0.016 H |
| Last Trade | 0.008 |
|---|---|
| Change% | 0.0000 |
| 52 W H/L | 0.016/0.007 |
| EBITDA | -1.282 M |
|---|---|
| NPAT After Abnormal Items | -1.487 M |
| Equity | 16.416 M |
| ROE% | -9.06% |
| Total Liabilities | 963,680 |
|---|---|
| Total Revenue | 1.264 M |
| Cash and Cash Equivalents | 2.312 M |
Stock Information
| Share price | 0.008 |
|---|---|
| Market Cap | 14.36 M |
| Price/Gross Cash Flow | -15.11 |
| Dividend Yield Excluding Special | 0.00% |
| Ending Shares | 1.795 B | 52-Week Range | 0.007-0.016 |
| P/E ratio | 0.000 |
|---|---|
| Sector P/E | -- | EPS | -0.10 |
| EV/EBITDA | -- |
| Net Profit Margin (%) | -1,462.38% |
| Gross Cash Flows Per Share | -0.00 |
| Net Gearing | -13.93% |
| Gross DPS (AUD) | 0 |
|---|---|
| Gross Dividend Yield (Annualized) | 0.00% |
| Earnings Yield | 0.000 |
| Net Tangible Asset (NTA) | 0.00 |
| Sales Per Share | 0.00 |
| Book Value Per Share | 0.01 |
Announcements
About Company
Founded in 1988, Medibio Limited (ASX: MEB) is involved in the operations of developing diagnostic systems for mental health illness in Australia and the United States. Mr. Brian Mower is the CFO and the interim CEO of the company. The company is currently headed in 100 Albert Road Level 4 South Melbourne, Australia.
Corporate Information
|
|
|
|
Level 4, 100 Albert Road, SOUTH MELBOURNE, VIC, AUSTRALIA, 3205
+61 3 9692 7222
Dividends
| Ex-Dividend Date | Franking | DPS (AUD) | Dividend Yield |
|---|---|---|---|
| 30/06/2021 | -- | 0.000 | 0.00% |
| 30/06/2020 | -- | 0.000 | 0.00% |
| 30/06/2019 | -- | 0.000 | 0.00% |
| 30/06/2018 | -- | 0.000 | 0.00% |
| 30/06/2017 | -- | 0.000 | 0.00% |
| 30/06/2016 | -- | 0.000 | 0.00% |
| 30/06/2015 | -- | 0.000 | 0.00% |
| 30/06/2014 | -- | 0.000 | 0.00% |
| 30/06/2013 | -- | 0.000 | 0.00% |
| 30/06/2012 | -- | 0.000 | 0.00% |
Event Calendar
| Event Type | Event Date | Event Year |
|---|---|---|
| Report (Annual) | 2022-08-30 | 2022 |
| Report (Prelim) | 2022-08-30 | 2022 |
| Report (Interim) | 2022-02-23 | 2022 |
| AGM | 2021-11-11 | 2021 |
Financials
| Breakdown | 30/06/2021 | 30/06/2020 | 30/06/2019 | 30/06/2018 | 30/06/2017 |
|---|---|---|---|---|---|
| Trading Revenue | 101,656 | 133,500 | 364,628 | 204,878 | 23,100 |
| Other Revenue | 1.163 M | 791,769 | 3.738 M | 2.257 M | 3.099 M |
| Total Revenue | 1.264 M | 925,269 | 4.102 M | 2.462 M | 3.122 M |
| Interest Income | 1,330 | 7,562 | 30,077 | 138,501 | 34,241 |
| Interest Expenses | -16,282 | -36,687 | -13,928 | -8,139 | -266,659 |
| Expenses | -2.538 M | -4.416 M | -10.164 M | -17.563 M | -10.948 M |
| EBITDA | -1.273 M | -3.491 M | -6.062 M | -15.101 M | -7.826 M |
| Depreciation and Amortization | -198,518 | -148,865 | 0 | -1.329 M | -1.727 M |
| Depreciation | -198,518 | -148,865 | 0 | 0 | 0 |
| Amortisation | 0 | 0 | 0 | -1.329 M | -1.727 M |
| EBIT | -1.472 M | -3.64 M | -6.062 M | -16.431 M | -9.553 M |
| Pre Tax Profit | -1.487 M | -3.669 M | -6.045 M | -16.3 M | -9.785 M |
| Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Profit After Tax | -1.487 M | -3.669 M | -6.045 M | -16.3 M | -9.785 M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Preference Dividend | 0 | 0 | 0 | 0 | 0 |
| Net Abnormal Items | 0 | -203,549 | -541,678 | 0 | 0 |
| Reported Net Profit After Abnormal Items | -1.487 M | -3.872 M | -6.587 M | -16.3 M | -9.785 M |
| Ending Shares | 1.795 B | 1.095 B | 256.127 M | 223.134 M | 163.769 M |
| Weighted Average Shares | 1.472 B | 882.415 M | 222.659 M | 203.865 M | 144.763 M |
| EPS After Abnormal Items (cents) | -0.1 | -0.44 | -2.96 | -8 | -6.76 |
| Breakdown | 30/06/2021 | 30/06/2020 | 30/06/2019 | 30/06/2018 | 30/06/2017 |
|---|---|---|---|---|---|
| Total Current Assets | 2.664 M | 861,696 | 1.532 M | 7.886 M | 7.365 M |
| Total Non Current Assets | 14.715 M | 13.152 M | 11.771 M | 11.178 M | 11.885 M |
| Total Assets | 17.38 M | 14.014 M | 13.303 M | 19.064 M | 19.25 M |
| Total Current Liabilities | 963,680 | 1.404 M | 4.699 M | 5.078 M | 5.936 M |
| Total Non Current Liabilities | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 963,680 | 1.404 M | 4.699 M | 5.078 M | 5.936 M |
| Net Assets | 16.416 M | 12.609 M | 8.604 M | 13.986 M | 13.314 M |
| Breakdown | 30/06/2021 | 30/06/2020 | 30/06/2019 | 30/06/2018 | 30/06/2017 |
|---|---|---|---|---|---|
| Net Operating Cash | -1.701 M | -3.589 M | -6.83 M | -12.268 M | -5.425 M |
| Net Invested Cash | -1.832 M | -1.505 M | -1.085 M | -399,615 | 34,241 |
| Net Financing Cash Flows | 4.922 M | 4.554 M | 3.125 M | 13.781 M | 9.361 M |
| Beginning Cash | 812,503 | 1.333 M | 6.123 M | 5.01 M | 1.04 M |
| End Cash Position | 2.312 M | 812,503 | 1.333 M | 6.123 M | 5.01 M |
| Exchange Rate Adjustments | 109,742 | 19,157 | 0 | 0 | 0 |
| Other Cash Adjustments | 0 | 0 | 0 | 0 | 0 |
| Ending Cash | 2.312 M | 812,503 | 1.333 M | 6.123 M | 5.01 M |
© Morningstar, Inc. 2021. All rights reserved. Neither Morningstar, its affiliates, nor the content providers guarantee the market indices, commodities and regulatory news headlines, and other data or content contained herein to be accurate, complete, or timely, and nor shall they have any liability for its use or distribution. The data contained herein: (1) is proprietary to Morningstar and/or its affiliates (collectively, “Morningstar”) and/or their content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete, or timely. Our publications, ratings and products should be viewed as an additional investment resource, and not as your sole source of information. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your financial situation, contact a professional financial adviser. Some material is copyrighted and published under licence from ASX Operations Pty. Ltd. ACN 004523782.